The cholangiopathies

Liver Disease in Children, Third Edition

Volumn , Issue , 2007, Pages 35-70

  Desmet, Valeer J ^a   Roskams, Tania A D ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955941183     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511547409.006     Document Type: Chapter

References (424)

1. Severn CB. A morphological study of the development of the humanliver. II. Establishment of liver parenchyma, extrahepatic ducts and associated venous channels. Am J Anat 1972;133:85–107.
2. Dubois AM. The embryonic liver. In: Rouillen C, ed. The liver. New York: Academic Press, 1963:1–39.
3. Tan CEL, Moscoso GJ. The developing human biliary systemat the porta hepatis level between 29 days and 8 weeks of gestation: a way to understanding biliary atresia. Part 1. Pathol Int 1994;44:587–99.
4. Dubois AM. The embryonic liver. In: Rouiller C, ed. The liver. New York: Academic Press, 1963:1–39.
5. Das KM, Squillante L, Chitayet D, et al. Simultaneous appearance of a unique commonepitope in fetal colon, skin and biliary epithelial cells. A possible link for extracolonic manifestations in ulcerative colitis. J Clin Gastroenterol 1992;15:311–16.
6. Landry C, Clotman F, Hioki T, et al. HNF-6 is expressed in endodermderivatives and nervous system of the mouse embryo and participates to the cross-regulatory network of liver-enriched transcription factors. Dev Biol 1997;192:247–57.
7. Rausa F, Samadani U, Ye H, et al. The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas. Dev Biol 1997;192:228–46.
8. Kalinichenko VV, Zhou Y, Bhattacharyya D, et al. Haploinsufficiency of the mouse Forkhead Box f1 gene causes defects in gall bladder development. J Biol Chem 2002;277:12369–74.
9. Jorgensen M. The ductal plate malformation: a study of the intrahepatic bile duct lesion in infantile polycystic disease and congenital hepatic fibrosis. Acta Pathol Microbiol Scand 1977;257(Suppl):1–88.
10. Tan CEL, Moscoso GJ. The developing human biliary systemat the porta hepatis level between 11 and 25 weeks of gestation: a way to understanding biliary atresia. Part 2. Pathol Int 1994; 44:600–10.
11. Tan J, Hytiroglou P, Wieczorek R, et al. Immunohistochemical evidence for hepatic progenitor cells in liver diseases. Liver 2002;22:365–73.
12. Shiojiri N, Katayama H. Secondary joining of the bile ducts during the hepatogenesis of the mouse embryo. Anat Embryol 1987;177:153–63.
13. Mahlapuu M, Enerback S, Carlsson P. Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development 2001;128:2397–406.
14. Bloom W. The embryogenesis of human bile capillaries and ducts. Am J Anat 1926;36:451–62.
15. Elias H, Sherrick JC. Morphology of the liver. New York: Academic Press, 1969.
16. Desmet VJ, Van Eyken P. Embryology, malformations and malpositions of the liver. In: Haubrich W, Schaffner F, Berk JE, eds. Bockus gastroenterology, 5th ed. Philadelphia, PA: Saunders, 1995:1849–57.
17. Blankenberg TA, Lund JK, Ruebner BH. Normal and abnormal development of human intrahepatic bile ducts. An immunohistochemical perspective. In: Abramowsky CR, Bernstein J, Rosenberg HS, eds. Perspectives in pediatric pathology. Transplantation pathology—hepatic morphogenesis. Vol. 14. Basel: Karger, 1991:143–67.
18. Ruebner BH, Blankenberg TA, Burrows DA, et al. Development and transformation of the ductal plate in the developing human liver. Pediatr Pathol 1990;10:55–68.
19. Hammar JA. ¨ Uber die erste Entstehung der nicht kapillaren intrahepatischen Galleng¨ange beim Menschen. ZMikrosk Anat Forsch 1926;5:59–89.
20. Desmet VJ. Embryology of the liver and intrahepatic biliary tract, and an overview of malformations of the bile duct. In: Bircher J, Benharnou JP, Mc Intyre N, et al., eds. The Oxford textbook of clinical hepatology. Oxford, UK: Oxford University Press, 1999:51–61.
21. Vijayan V, Tan CE. Developing human biliary system in three dimensions. Anat Rec 1997;249:389–98.
22. Van Eyken P, Sciot R, Callea F, et al. The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology 1988;8:1586–95.
23. Haruna Y, Thung S, Gerber M. Cell lineage specific markers during human liver organogenesis and regeneration. Hepatology 1994;20:210A
24. Stosiek P, Kasper M, Karsten U. Expression of cytokeratin 19 during human liver organogenesis. Liver 1990;10:59–63.
25. Desmet VJ, Van Eyken P, Sciot R. Cytokeratins for probing cell lineage relationships in developing liver. Hepatology 1990; 12:1249–51.
26. Faa G, Van Eyken P, Roskams T, et al. Expression of cytokeratin 20 in developing rat liver and in experimental models of ductular and oval cell proliferation. J Hepatol 1998;29:628–33.
27. Van Eyken P, Sciot R, van Damme B, et al. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol 1987;412:63–72.
28. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11–24.
29. Lemaigre FP. Development of the biliary tract. Mech Dev 2003; 120:81–7.
30. Clotman F, Jacquemin P, Plumb-Rudewiez N, et al. Control of liver cell fate decision by a gradient of TGFbeta signaling modulated by Onecut transcription factors. Genes Dev 2005;19:1849–54.
31. Croquelois A, Blindenbacher A, Terracciano L, et al. Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice. Hepatology 2005;41:487–96.
32. Krupczak-Hollis K, Wang X, Kalinichenko VV, et al. The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev Biol 2004;276:74–88.
33. Sergi C, Adam S, Kahl P, et al. The remodeling of the primitive human biliary system. Early Hum Dev 2000;58:167–78.
34. Kahn E, Markowitz J, Aiges H, et al. Human ontogeny of the bile duct to portal space ratio. Hepatology 1989;10:21–3.
35. Doljanski L, Roulet F. Ueber die gestaltende Wechselwirkung zwischen dem Epithel und dem Mesenchym, zugleich ein Beitrag zur Histogenese der sogenannten “Gallengangswucherungen. ” Virchows Arch [A] 1934;292:256–67.
36. Terada T, Kitamura Y, Nakanuma Y. Normal and abnormal development of the humanintrahepatic biliary system: a review. Tohoku J Exp Med 1997;181:19–32.
37. Desmet VJ. Embryogenèse des voies biliaires. Med Ther 1995; 1:227–35.
38. Roskams T, van Eyken P, Desmet V. Human liver growth and development. In: Strain AJ, Diehl AM, eds. Liver growth and repair. London: Chapman and Hall, 1998:541–57.
39. Nakanuma Y, Hoso M, Sanzen T, et al. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech 1997;38: 552–70.
40. Balistreri W. Concluding remarks. 5th International Sendai Symposium on Biliary Atresia. In: Ohi R, ed. Biliary atresia. Tokyo: ICOM Associates, 1991:293–7.
41. Couvelard A, Bringuier AF, Dauge MC, et al. Expression of integrins during liver organogenesis in humans. Hepatology 1998;27:839–47.
42. Terada T, Ashida K, Kitamura Y, et al. Expression of epithelialcadherin, alpha-catenin and beta-catenin during human intrahepatic bile duct development: a possible role in bile duct morphogenesis. J Hepatol 1998;28:263–9.
43. Dudas J, Papoutsi M, Hecht M, et al. The homeobox transcription factor Prox1 is highly conserved in embryonic hepatoblasts and in adult and transformed hepatocytes, but is absent from bile duct epithelium. Anat Embryol (Berl) 2004;208:359–66.
44. Shiojiri N, Takeshita K, Yamasaki H, et al. Suppression of CEBP alpha expression in biliary cell differentiation fromhepatoblasts during mouse liver development. J Hepatol 2004;41:790–8.
45. Quondamatteo F, Knittel T, Mehde M, et al. Matrix metalloproteinases in early human liver development. Histochem Cell Biol 1999;112:277–82.
46. Libbrecht L, Cassiman D, Desmet V, et al. Expression of neural cell adhesion molecule in human liver development and in congenital and acquired liver diseases. Histochem Cell Biol 2001;116:233–9.
47. Shiojiri N, Nagai Y. Preferential differentiation of the bile ducts along the portal vein in the development of mouse liver. Anat Embryol (Berl) 1992;185:17–24.
48. Libbrecht L, Cassiman D, Desmet V, et al. The correlation between portalmyofibroblasts and development of intrahepatic bile ducts and arterial branches in human liver. Liver 2002;22: 252–8.
49. Terada T, Nakanuma Y. Development of human peribiliary capillary plexus: a lectin-histochemical and immunohistochemical study. Hepatology 1993;18:529–36.
50. Clotman F, Lannoy VJ, Reber M, et al. The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 2002;129:1819–28.
51. Clotman F, Libbrecht L, Gresh L, et al. Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development. J Hepatol 2003;39:686–92.
52. Coffinier C, Gresh L, Fiette L, et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. Development 2002;129:1829–38.
53. Xue Y, Gao X, Lindsell CE, et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 1999;8:723–30.
54. Crosnier C, Attie-Bitach T, Encha-Razavi F, et al. JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 2000;32:574–81.
55. Louis AA, Van Eyken P, Haber BA, et al. Hepatic jagged1 expression studies. Hepatology 1999;30:1269–75.
56. McCright B, Lozier J, Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002;129:1075–82.
57. Kodama Y, Hijikata M, Kageyama R, et al. The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 2004;127:1775–86.
58. Nijjar SS, Wallace L, Crosby HA, et al. Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects. Am J Pathol 2002;160:1695–703.
59. Flynn DM, Nijjar S, Hubscher SG, et al. The role of Notch receptor expression in bile duct development and disease. J Pathol 2004;204:55–64.
60. Chen HL, Chen HL, Liu YJ, et al. Developmental expression of canalicular transporter genes in human liver. J Hepatol 2005; 43:472–7.
61. De Wolf-Peeters C, De Vos R, Desmet V, et al. Electron microscopy and morphometry of canalicular differentiation in fetal and neonatal rat liver. Exp Mol Pathol 1974;21:339–50.
62. Kanamura S, Kanai K, Watanabe J. Fine structure and function of hepatocytes during development. J Electron Microsc Tech 1990;14:92–105.
63. Roskams T, Desmet VJ. Parathyroid hormone-related peptide and development of intrahepatic bile ducts in man. Int Hepatol Comm 1994;2:121–7.
64. Terada T, Nakanuma Y. Development of human intrahepatic peribiliary glands. Histological, keratin immunohistochemical, and mucus histochemical studies. Lab Invest 1993;68:261–9.
65. Crawford JM. Development of the intrahepatic biliary tree. Semin Liver Dis 2002;22:213–26.
66. Shankle WR, Landing BH, Gregg J. Normal organ weights of infants and children: graphs of values by age, with confidence intervals. Pediatr Pathol 1983;1:399–408.
67. Kiernan F. The anatomy and physiology of the liver. Philos Trans R Soc Lond 1833;123:711–70.
68. Mall FP. A study of the structural unit of the liver. Am J Anat 1906;5:227–308.
69. Rappaport AM. The microcirculatory hepatic unit. Microvasc Res 1973;6:212–228.
70. Lamers WH, Moorman AFM, Charles R. The metabolic lobulus, a key to the architecture of the liver. In: Gumucio JJ, ed. Revisiones sobre biologia cellular. Cell biology reviews. Vol. 19. Berlin: Springer International. 1989:5–26.
71. Matsumoto T, Komori R, Magara T, et al. Astudy on the normal structure of human liver, with special reference to its angioarchitecture. Jikeikai Med J 1979;26:1–40.
72. Matsumoto R, Kawakami M. The unit-concept of hepatic parenchyma –a re-examination based on angioarchitectural studies. Acta Pathol Jpn 1982;32:285–314.
73. Teutsch HF. The modular microarchitecture of human liver. Hepatology 2005;42:317–25.
74. Ekataksin W, Wake K. New concepts in biliary and vascular anatomy of the liver. In: Boyer JL, Ockner R, eds. Progress in liver disease. Philadelphia: WB Saunders Company, 1997:1–30.
75. Johnson F. The development of the lobule of the pig’s liver. Am J Anat 1919;25:299–331.
76. Landing BH, Wells TR. Considerations of some architectural properties of the biliary tree and liver in childhood. In: Abramowsky CR, Bernstein J, Rosenberg HS, eds. Transplantation pathology –hepatic morphogenesis. Perspectives in pediatric pathology. Vol. 14. Basel: Karger, 1991:122–42.
77. Ludwig J, Ritman EL, La Russo NF, et al. Anatomy of the human biliary system studied by quantitative computer-aided threedimensional imaging techniques. Hepatology 1998;27:893–9.
78. Artavanis-Tsakonas S, Matsuno K, Fortini ME. Notch signaling. Science 1995;268:225–32.
79. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770–6.
80. Roskams TA, Theise ND, Balabaud C, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004;39:1739–45.
81. Marchal GJ, Desmet VJ, Proesmans WC, et al. Caroli disease: high frequency US and pathologic findings. Radiology 1986; 158:507–11.
82. Van Eyken P, Desmet VJ. Disordered embryogenesis of the hepatobiliary tract. In: Prieto J, Rodes JS, Shafritz DA, eds. Hepatobiliary diseases. Berlin: Springer, 1992:931–70.
83. Inui A, Fujisawa T, Suemitsu T, et al. A case of Caroli’s disease with special reference to hepatic CT and US findings. J Pediatr Gastroenterol Nutr 1992;14:463–6.
84. Brancatelli G, Federle MP, Vilgrain V, et al. Fibropolycystic liver disease:CTand MRimaging findings. Radiographics 2005; 25:659–70.
85. Levy AD, Rohrmann CA Jr. Biliary cystic disease. Curr Probl Diagn Radiol 2003;32:233–63.
86. Zeitoun D, Brancatelli G, Colombat M, et al. Congenital hepatic fibrosis: CT findings in 18 adults. Radiology 2004;231:109–16.
87. Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation. ” Hepatology 1992;16:1069–83.
88. Desmet VJ. What is congenital hepatic fibrosis?Histopathology 1992;20:465–77.
89. Johnson CA, Gissen P, Sergi C. Molecular pathology and genetics of congenital hepatorenal fibrocystic syndromes. J Med Genet 2003;40:311–19.
90. Desmet VJ, Callea F. Cholestatic syndromes of infancy and childhood. In: Zakim D, Boyer TD, eds. Hepatology. A textbook of liver disease. Philadelphia: WB Saunders, 1996:1649–98.
91. Lefkowitch JH. Biliary atresia. Mayo Clin Proc 1998;73:90–5.
92. Kasai M, Kimuna S, Asakura S, et al. Surgical treatment of biliary atresia. J Pediatr Surg 1968;3:665–75.
93. Howard ER. Extrahepatic biliary atresia. A review of current management. Br J Surg 1983;70:193–7.
94. Ohya T, Fujimoto T, Shimomura H, et al. Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. J Pediatr Surg 1995;30:515–18.
95. Witzleben CL. The pathogenesis of biliary atresia. In: Javitt NB, ed. Neonatal hepatitis and biliary atresia. Washington, DC: US Department of Health, Education and Welfare, 1979:339–50.
96. Witzleben CL. Pathogenesis of bile duct paucity: observations in extrahepatic biliary atresia and arteriohepatic dysplasia. In: Waldschmidt J, Charissis G, Schier F, eds. Cholestasis in neonates. WZuckschwerdt: München, 1988:53–61.
97. Haas JE. Bile duct and liver pathology in biliary atresia. World J Surg 1978;2:561–9.
98. Kasai M. Treatment of biliary atresia with special reference to hepatic porto-enterostomy and its modifications. In: Bill AH, Kasai M, eds. Progress of pediatric surgery. Baltimore: University Park Press, 1974:5–52.
99. Gautier M, Jehan P, Odièvre M. Histologic study of biliary fibrous remnants in 48 cases of extra-hepatic biliary atresia: correlation with postoperative bile flow restoration. J Pediatr 1976;89:704–9.
100. Miyano T, Surugo K, Tsuchiya H. A histopathological study of the remnant of extrahepatic bile duct in so-called uncorrectable biliary atresia. J Pediatr Surg 1977;12:19–25.
101. Suruga K, Miyano T, Arai T, et al. A study of patients with longtermbile flowafter hepatic portoenterostomy for biliary atresia. J Pediatr Surg 1985;20:252–5.
102. Schweizer P. Extrahepatische Gallengangsatresie –Eine analytische Bewertung prognostischer Faktoren. Ein Beitrag zu einem rationelen Therapieansatz. Z Kinderchir 1990;45:365–70.
103. Tan CE, Davenport M, Driver M, et al. Does the morphology of the extrahepatic biliary remnants in biliary atresia influence survival? A review of 205 cases. J Pediatr Surg 1994;29:1459–64.
104. Dolgin SE. Answered and unanswered controversies in the surgical management of extra hepatic biliary atresia. Pediatr Transplant 2004;8:628–31.
105. Schweizer P, Muller G. Gallengangsatresie. Cholestase- Syndrome im Neugeborenen- und Suglingsalter. Stuttgart: Hippokrates Verlag, 1984.
106. Desmet VJ. Pathology of paediatric cholestasis. In: Lentze M, Reichen J, eds. Paediatric cholestasis. Novel approaches to treatment. Dordrecht: Kluwer Academic Publishers, 1992:55–73.
107. Cocjin J, Rosenthal P, Buslon V, et al. Bile ductule formation in fetal, neonatal, and infant livers compared with extrahepatic biliary atresia. Hepatology 1996;24:568–74.
108. Brough AJ, Bernstein J. Morphologic approachto the evaluation of infantile conjugated hyperbilirubinemia. In: Javitt NB, ed. Neonatal hepatitis and biliary atresia. DHEW publication no. (NIH) 79–1296. Washington, DC: US Department of Health, Education and Welfare, 1979;381–8.
109. Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver 1993; 13:113–22.
110. Roskams T, Desmet V. Ductular reaction and its diagnostic significance. Semin Diagn Pathol 1998;15:259–69.
111. Roskams T. The role of immunohistochemistry in diagnosis. Clin Liver Dis 2002;6:571–89, x.
112. Azar G, Beneck D, Lane B, et al. Atypical morphologic presentation of biliary atresia and value of serial liver biopsies. J Pediatr Gastroenterol Nutr 2002;34:212–15.
113. dos Santos JL, da Silveira TR, da Silva VD, et al. Medial thickening of hepatic artery branches in biliary atresia. Amorphometric study. J Pediatr Surg 2005;40:637–42.
114. Ho CW, Shioda K, Shirasaki K, et al. The pathogenesis of biliary atresia: a morphological study of the hepatobiliary system and the hepatic artery. J Pediatr Gastroenterol Nutr 1993;16:53–60.
115. Azarow KS, Phillips MJ, Sandler AD, et al. Biliary atresia: should all patients undergo a portoenterostomy? J Pediatr Surg 1997;32:168–72; discussion 172–4.
116. Lilly JR, Alejandro M, Hernandez C, et al. Surgery of biliary atresia. In: Balistreri WF, Stocker JT, eds. Pediatric hepatology. New York: Hemisphere Publishing Corporation, 1990:19–27.
117. Lilly JR, Karrer FM. Contemporary surgery of biliary atresia. Pediatr Clin North Am 1985;32:1233–46.
118. Landing BH, Wells TR, Ramicone E. Time course of the intrahepatic lesion of extrahepatic biliary atresia. A morphometric study. Pediatr Pathol 1985;4:309–19.
119. Aronson DC, de Haan J, James J, et al. Quantitative aspects of the parenchyma-stromarelationship in experimentally induced cholestasis. Liver 1988;8:116–26.
120. Raweily EA, Gibson AAM, Burt AD. Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia. Histopathology 1990;17:521–7.
121. Low Y, Vijayan V, Tan CE. The prognostic value of ductal plate malformation and other histologic parameters in biliary atresia: an immunohistochemical study. J Pediatr 2001;139:320–2.
122. Desmet VJ. Cholangiopathies: past, present and future. Semin Liver Dis 1987;7:67–76.
123. Ryckman FC, Alonso MH, Bucuvalas JC, et al. Biliary atresia –surgical management and treatment options as they relate to outcome. Liver Transpl Surg 1998;4(5 suppl 1):S24–33.
124. Bates MD, Bucuvalas JC, Alonso MH, et al. Biliary atresia: pathogenesis and treatment. Semin Liver Dis 1998;18:281–93.
125. Laurent J, Gauthier F, Bernard O, et al. Long-term outcome after surgery for biliary atresia. Study of 40 patients surviving more than 10 years. Gastroenterology 1990;99:1793–7.
126. Fabbretti G, Gosseye S, Brisigutti M, et al. Liver transplantation after unsuccessful porto-enterostomy for extra-hepatic biliary atresia (EHBDA): morphologic study of 31 removed livers. In: Ohi R, ed. Biliary atresia. Tokyo: ICOM Associates, 1991: 70–4.
127. Petersen C. Surgery in biliary atresia –futile or futuristic? Eur J Pediatr Surg 2004;14:226–9.
128. Callea F, Facchetti F, Lucini L, et al. Liver morphology in anicteric patients at long-term follow-up after Kasai operation: a study of 16 cases. In: Ohi R, ed. Biliary atresia. Tokyo: ICOM Associates, 1991:304–10.
129. Perlmutter DH, Shepherd RW. Extrahepatic biliary atresia: a disease or a phenotype? Hepatology 2002;35:1297–304.
130. Bezerra JA. Potential etiologies of biliary atresia. Pediatr Transplant 2005;9:646–51.
131. Squires RH Jr. From whence does biliary atresia arise? Pediatr Transplant 2005;9:145–7.
132. Mack CL, Sokol RJ. Unraveling the pathogenesis and etiology of biliary atresia. Pediatr Res 2005;57(5 pt 2):87R–94R.
133. Sokol RJ, Mack C, Narkewicz MR, et al. Pathogenesis and outcomeof biliary atresia: current concepts. J Pediatr Gastroenterol Nutr 2003;37:4–21.
134. Carmi R, Magee CA, Neill CA, et al. Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneity suggested by distinctive patterns of associations. Am J Med Genet 1993;45:683–93.
135. Mazziotti MV, Willis LK, Heuckeroth RO, et al. Anomalous development of the hepatobiliary systemin the Inv mouse. Hepatology 1999;30:372–8.
136. Schon P, Tsuchiya K, Lenoir D, et al. Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene, the ortholog of amurine gene implicated in left-right axis development and biliary atresia. Hum Genet 2002;110:157–65.
137. Jacquemin E, Cresteil D, Raynaud N, et al. CFCI gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr 2002;34:326–7.
138. Ware SM, Peng J, Zhu L, et al. Identification and functional analysis of ZIC3mutations in heterotaxy and related congenital heart defects. Am J Hum Genet 2004;74:93–105.
139. Zhang DY, Sabla G, Shivakumar P, et al. Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology 2004;39:954–62.
140. Kohsaka T, Yuan ZR, Guo SX, et al. The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia. Hepatology 2002;36(4 pt 1):904–12.
141. Sasaki H, Nio M, Iwami D, et al. Cytokeratin subtypes in biliary atresia: immunohistochemical study. Pathol Int 2001;51: 511–18.
142. Omary MB, Ku NO, Toivola DM. Keratins: guardians of the liver. Hepatology 2002;35:251–7.
143. Tan CE, Chan VS, Yong RY, et al. Distortion in TGF beta 1 peptide immunolocalization in biliary atresia: comparisonwith the normal pattern in the developing human intrahepatic bile duct system. Pathol Int 1995;45:815–24.
144. Sasaki H, Nio M, Iwami D, et al. E-cadherin, alpha-catenin and beta-catenin in biliary atresia: correlation with apoptosis and cell cycle. Pathol Int 2001;51:923–32.
145. Funaki N, Sasano H, Shizawa S, et al. Apoptosis and cell proliferation in biliary atresia. J Pathol 1998;186:429–33.
146. Colombo C, Zuliani G, Ronchi M, et al. Biliary bile acid composition of the human fetus in early gestation. Pediatr Res 1987;21:197–200.
147. Yamamoto K, Fisher MM, Phillips MJ. Hilar biliary plexus in human liver. A comparative study of the intrahepatic bile ducts in man and animals. Lab Invest 1985;52:103–6.
148. Lester R, St Pyrek J, Little JM, Adcock EW. Nature of bile acids in the fetus andnewborninfant. JPediatr Gastroenterol Nutr 1983; 2(suppl 1):S197–206.
149. Hata Y, Sasaki F, Takahashi H, et al. Fetal bile acids in congenital biliary atresia. In: Ohi R, ed. Biliary atresia. Tokyo: ICOM Associates, 1991:182–6.
150. Rolleston H, Hayne L. A case of congenital hepatic cirrhosis with obliterative cholangitis (congenital obliteration of the bile ducts). BMJ 1901;1:758–60.
151. Uflacker R, Pariente DM. Angiographic findings in biliary atresia. Cardiovasc Intervent Radiol 2004;27:486–90.
152. Harper PAW, Plant JW, Unger DB. Congenital biliary atresia and jaundice in lambs and calves. Aust Vet J 1990;67:18–22.
153. Alagille D, Odievre M, Gautier M, et al. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental and sexual development and cardiac murmur. J Pediatr 1975;86:63–71.
154. Treem WR, Krzymowski GA, Cartun RW, et al. Cytokeratin immunohistochemical examination of liver biopsies in infants with Alagille syndrome and biliary atresia. J Pediatr Gastroenterol Nutr 1992; 15:73–80.
155. Faa G, Van Eyken P, Demelia L, et al. Idiopathic adulthood ductopenia presentingwith chronic recurrent cholestasis. Acase report. J Hepatol 1991;12:14–20.
156. Hadchouel M, Hugon RN, Gautier M. Reduced ratio of portal tracts to paucity of intrahepatic bile ducts. Arch Pathol Lab Med 1978;102:402–3.
157. Birnbaum A, Suchy FJ. The intrahepatic cholangiopathies. Semin Liver Dis 1998;18:263–9.
158. Kahn E. Paucity of interlobular bile ducts. Arteriohepatic dysplasia and nonsyndromic duct paucity. In: Abramowsky CR, Bernstein J, Rosenberg HS, eds. Perspectives in pediatric pathology. Transplantation pathology –hepatic morphogenesis, Vol. 14. Basel: Karger, 1991:168–215.
159. Hashida Y, Yunis EJ. Syndromatic paucity of interlobular bile ducts: hepatic histopathology of the early and endstage liver. Pediatr Pathol 1988;8:1–15.
160. Krantz ID, Piccoli DA, Spinner NB. Alagille syndrome. J Med Genet 1997;34:152–7.
161. Harper JA, Yuan JS, Tan JB, et al. Notchsignaling in development and disease. Clin Genet 2003;64:461–72.
162. Balistreri WF, Bezerra JA, Jansen P, et al. Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference. Hepatology 2005;42:222–35.
163. Lorent K, Yeo SY, Oda T, et al. Inhibition of Jagged-mediated Notchsignaling disrupts zebrafish biliarydevelopment and generates multi-organ defects compatible with an Alagille syndrome phenocopy. Development 2004;131:5753–66.
164. Boyer J, Crosnier C, Driancourt C, et al. Expression of mutant JAGGED1 alleles in patients with Alagille syndrome. Hum Genet 2005;116:445–53.
165. Loomes KM, Taichman DB, Glover CL, et al. Characterizationof Notch receptor expression in the developing mammalian heart and liver. Am J Med Genet 2002; 112:181–9.
166. Deutsch GH, Sokol RJ, Stathos TH, et al. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome. Pediatr Dev Pathol 2001;4:559–63.
167. Emerick KM, Rand EB, Goldmuntz E, et al. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology 1999;29:822–9.
168. Libbrecht L, Spinner NB, Moore EC, et al. Peripheral bile duct paucity and cholestasis in the liver of a patient with Alagille syndrome: further evidence supporting a lack of postnatal bile duct branching and elongation. Am J Surg Pathol 2005;29:820–6.
169. Aburano T, Yokoyama K, Takayama T, et al. Distinct hepatic retention of Tc-99m IDA in arteriohepatic dysplasia (Alagille syndrome). Clin Nucl Med 1989;14:874–6.
170. Torizuka T, Tamaki N, Fujita T, et al. Focal liver hyperplasia in Alagille syndrome: assessment with hepatoreceptor and hepatobiliary imaging. J Nucl Med, 1996;37:1365–7.
171. Jinguji M, Tsuchimochi S, Nakajo M, et al. Scintigraphic progress of the liver in a patient with Alagille syndrome (arteriohepatic dysplasia). Ann Nucl Med 2003;17:693–7.
172. Kamath BM, Spinner NB, Emerick KM, et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 2004;109:1354–8.
173. Spinner NB. Alagille syndrome and the notch signaling pathway: new insights into human development. Gastroenterology 1999;116:1257–60.
174. Makos BK, Youson JH. Serum levels of bilirubin and biliverdin in the sea lamprey, Petromyzon marinus L., before and after their biliary atresia. Comp Biochem Physiol 1987;87A:761–4.
175. Hoffenberg EJ, Narkewicz MR, Sondheimer JM, et al. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr 1995; 127:220–4.
176. Wegmann C, Munzenmaier R, Dormann AJ, et al. [Ticlopidineinduced acute cholestatic hepatitis]. Dtsch Med Wochenschr 1998;123:146–50.
177. Kim B, Park SH, Yang HR, et al. Hepatocellular carcinoma occurring in Alagille syndrome. Pathol Res Pract 2005;201:55–60.
178. Furuya KN, Roberts EA, Canny GJ, et al. Neonatal hepatitis syndrome with paucity of interlobular bile ducts in cystic fibrosis. J Pediatr Gastroenterol Nutr 1991;12:127–30.
179. Jansen PL, Sturm E. Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int 2003;23:315–22.
180. Bove KE, Heubi JE, Balistreri WF, et al. Bile acid syntheticdefects and liver disease: a comprehensive review. Pediatr Dev Pathol 2004;7:315–34.
181. Kahn EI, Daum F, Markowitz J, et al. Arteriohepatic dysplasia II. Hepatobiliary morphology. Hepatology 1983;3:77–84.
182. Gosseye S, Otte JB, De Meyer R, et al. A histological study of extrahepatic biliary atresia. Acta Paediatr Belg 1977;30:85–90.
183. Lilly JR. The surgery of biliary hypoplasia. J Pediatr Surg 1976; 11:815–21.
184. Yamagiwa I, Obata K, Hatanaka Y, et al. Clinico-pathological studies on a transitional type between extrahepatic biliary atresia and paucity of interlobular bile ducts. Jpn J Surg 1993; 23:307–14.
185. Amedee-Manesme O, Bernard O, Brunelle F, et al. Sclerosing cholangitis with neonatal onset. J Pediatr 1987;111:225–9.
186. Guay-Woodford LM, Galliani CA, Musulman-Mroczek E, et al. Diffuse renal cystic disease in children:morphologic and genetic correlations. Pediatr Nephrol 1998;12:173–82.
187. Caroli J, Corcos V. Maladies des voies biliaires intrah patiques segmentaires. Paris: Masson, 1964.
188. Welling LW, Grantham JJ. Cystic diseases of the kidney. In: Tisher CC, Brenner BM, eds. Renal pathology with clinical and functional correlations. Philadelphia: JB Lippincott, 1989:1233–75.
189. Henry X, Marrasse E, Stoppa R, et al. Association maladie de Caroli –kyste du cholédoque –fibrose hépatique congénitale –polykystose rénale. Chirurgie 1987;113:834–43.
190. Buts JP, Otte JB, Claus D, et al. Kyste du cholédoque: un cas avec dilatation des voies biliaires intrahépatiques et fibrose hépatique congénitale. Helv Paediatr Acta 1980;35:289–95.
191. Cole BR. Autosomal recessive polycystic kidney disease. In: Gardner KD Jr, Bernstein J, eds. The cystic kidney. Dordrecht: Kluwer Academic Publishers, 1990:327–50.
192. Zerres K, Rudnik-Schöneborn S, Senderek J, et al. Autosomal recessive polycystic kidney disease (ARPKD). J Nephrol 2003; 16:453–8.
193. Onuchic LF, Furu L, Nagasawa Y, et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containingmultiple immunoglobulin-like plexintranscription- factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 2002; 70:1305–17.
194. Wang S, Luo Y, Wilson PD, et al. The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area. J Am Soc Nephrol 2004;15:592–602.
195. Masyuk TV, Huang BQ, Ward CJ, et al. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology 2003;125:1303–10.
196. D’Agata ID, Jonas MM, Perez-Atayde AR, et al. Combined cystic disease of the liver and kidney. Semin Liver Dis 1994; 14:215–28.
197. Bergmann C, Senderek J, Windelen E, et al. Clinical consequences of PKHD1 mutations in 164 patients with autosomalrecessive polycystic kidney disease (ARPKD). Kidney Int 2005; 67:829–48.
198. Gattone VH 2nd, Mac Naughton KA, Kraybill AL. Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene. Anat Rec 1996;245:488–99.
199. Guay-Woodford LM, Green WJ, Lindsey JR, et al. Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated. Hum Mol Genet 2000;9:769–78.
200. Zou MH, Hou XY, Shi CM, et al. Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem 2002;277:32552–7.
201. Yoder BK, Tousson A, Millican L, et al. Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium. Am J Physiol Renal Physiol 2002;282:F541–52.
202. Moser M, Matthiesen S, Kirfel J, et al. A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD). Hepatology 2005; 41:1113–21.
203. Sanzen T, Harada K, Yasoshima M, et al. Polycystic kidney rat is a novel animal model of Caroli’s disease associated with congenital hepatic fibrosis. Am J Pathol 2001;158:1605–12.
204. Masyuk TV, Huang BQ, Masyuk AI, et al. Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease. Am J Pathol 2004;165:1719–30.
205. Blyth H, Ockenden BG. Polycystic disease of kidneys and liver presenting in childhood. J Med Genet 1971;8:257–84.
206. Rossetti S, Torra R, Coto E, et al. A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int 2003;64:391–403.
207. Witzleben CL. Cystic diseases of the liver. In: Zakim D, Boyer TD, eds. Hepatology. A textbook of liver disease. 2nd ed. Vol. 2. Philadelphia: WB Saunders, 1990:1395–411.
208. Nakanuma Y, Terada T, Ohta G, et al. Caroli’s disease in congenital hepatic fibrosis and infantile polycystic disease. Liver 1982;2:346–54.
209. Osathanondh V, Potter EL. Pathogenesis of polycystic kidneys. Arch Pathol 1964;77:466–73.
210. Lieberman E, Salinas-Madrigal L, Gwinn JL, et al. Infantile polycystic disease of the kidneys and liver. Clinical, pathological and radiological correlations and comparison with congenital hepatic fibrosis. Medicine 1971;50:277–318.
211. Bernstein J, Stickler GB, Neel IV. Congenital hepatic fibrosis: evolving morphology. APMIS Suppl 1988;4:17–26.
212. Premkumar A, Berdon WE, Levy J, et al. The emergence of hepatic fibrosis and portal hypertension in infants and children with autosomal recessive polycystic kidney disease: initial and follow-up sonographic and radiographic findings. Pediatr Radiol 1988;18:123–9.
213. Gang D, Herrin J. Infantile polycystic disease of the liver and kidneys. Clin Nephrol 1986;25:28–36.
214. Kerr DNS, Harrison CV, Sherlock S, et al. Congenital hepatic fibrosis. Q J Med 1961;30:91–117.
215. Alvarez F, Bernard O, Brunelle F, et al. Congenital hepatic fibrosis in children. J Pediatr 1981;99:370–5.
216. Matsuda O, Ideura T, Shinoda T, et al. Polycystic kidney of autosomal dominant inheritance, polycystic liver and congenital hepatic fibrosis in a single kindred. Am J Nephrol 1990;10:237–41.
217. Tazelaar HD, Payne JA, Patel S. Congenital hepatic fibrosis and asymptomatic familial adult-type polycystic disease in a 19-year old woman. Gastroenterology 1984;86:757–60.
218. Devos M, Barbier F, Cuvelier C. Congenital hepatic fibrosis. J Hepatol 1988;6:222–8.
219. Cobben JM, Breuning MH, Schoots C, et al. Congenital hepatic fibrosis in autosomal-dominant polycystic kidney disease. Kidney Int 1990;38:880–5.
220. Lipschitz B, Berdon WE, Defelice AR, et al. Association of congenital hepatic fibrosiswith autosomaldominantpolycystic kidney disease. Report of a family with review of literature. Pediatr Radiol 1993;23:131–3.
221. de Koning TJ, Nikkels PG, Dorland L, et al. Congenital hepatic fibrosis in 3 siblings with phosphomannose isomerase deficiency. Virchows Arch 2000;437:101–5.
222. Schwarzenberg SJ. Congenital hepatic fibrosis –is it really a matter of “a spoonful of sugar?” Hepatology 1999;30:582–3.
223. Clermont RJ, Maillard JN, Benhamou JP, et al. Fibrosehépatique congénitale. Can Med Assoc J 1967;97:1272–8.
224. Shneider BL, Magid MS. Liver disease in autosomal recessive polycystic kidney disease. Pediatr Transplant 2005;9:634–9.
225. Ghishan FK, Younoszai MK. Congenital hepatic fibrosis: a disease with diverse manifestations. Am J Gastroenterol 1981;75: 317–20.
226. Murray-Lyon IM, Ockenden BG, Williams R. Congenital hepatic fibrosis –is it a single clinical entity? Gastroenterology 1973; 64:653–6.
227. Summerfield JA, Nagafuchi Y, Sherlock S, et al. Hepatobiliary fibropolycystic disease: a clinical and histological review of 51 patients. J Hepatol 1986;2:141–56.
228. Potet F, Mulas Q, Feldmann G, et al. Problèmes anatomocliniques posés par la fibrose hépatique congénitale. Cah Med (Europa Medica) 1971;12:1015–30.
229. Nathan M, Batsakis JG. Congenital hepatic fibrosis. Surg Gynecol Obstet 1969;128:1033–41.
230. Hausner RJ, Alexander RW. Localized congenital hepatic fibrosis presenting as an abdominal mass. Hum Pathol 1978; 9:473–6.
231. Zlatkovic M, Duricic S, Plamenac P. Congenital hepatic fibrosis of heterotopic hepatic tissue. Pathol Res Pract 1998;194: 523–6.
232. Phillips MJ, Poucell S, Patterson J, et al. The liver. An atlas and text of ultrastructural pathology. New York: Raven Press, 1987:524.
233. Bianchi L, Reichen J. A 20-year-old woman with portal hypertension and a cholestatic syndrome. Hepatology 1994;20:515–22.
234. de Ledinghen V, Le Bail B, Trillaud H, et al. Case report: secondary biliary cirrhosis possibly related to congenital hepatic fibrosis. Evidence for decreased number of portal branch veins and hypertrophic peribiliary vascular plexus. J Gastroenterol Hepatol 1998;13:720–4.
235. Parker RGF. Fibrosis of the liver as a congenital anomaly. J Pathol Bacteriol 1956;71:359–68.
236. Adams CM, Danks DM, Campbell PE. Comments upon the classification of infantile polycystic diseases of the liver and kidney, based upon three-dimensional reconstruction of the liver. J Med Genet 1974;11:234–43.
237. Takatori M, Iwabuchi S, Hayashi T, et al. Congenital hepatic fibrosis with fatal cholestatic liver damage. Intern Med 2000;39: 930–5.
238. Bernstein J, Gardner KD Jr. Renal cystic disease and renal dysplasia. In:Walsh PC, Gitters RF, Perlmutter AD, Stamey TA, eds. Campbell’s urology. 5th ed. Philadelphia: WB Saunders, 1986: 1760–803.
239. Gresh L, Fischer E, Reimann A, et al. A transcriptional network in polycystic kidney disease. EMBO J 2004;23:1657–68.
240. Hiesberger T, Shao X, Gourley E, et al. Role of the hepatocyte nuclear factor-1beta (HNF-1beta) C-terminal domain in Pkhd1 (ARPKD) gene transcription and renal cystogenesis. J Biol Chem 2005;280:10578–86.
241. Hiesberger T, Bai Y, Shao X, et al. Mutation of hepatocyte nuclear factor-1beta inhibits Pkhd1 gene expression and produces renal cysts in mice. J Clin Invest 2004;113:814–25.
242. Montoli A, Colussi G, Massa O, et al. Renal cysts and diabetes syndrome linked tomutations of the hepatocyte nuclear factor- 1 beta gene: description of a new family with associated liver involvement. Am J Kidney Dis 2002;40:397–402.
243. Hildebrandt F, Omram H. New insights: nephronophthisismedullary cystic kidney disease. Pediatr Nephrol 2001;16:168–76.
244. Bissler JJ, Dixon BP. A mechanistic approach to inherited polycystic kidney disease. Pediatr Nephrol 2005;20:558–66.
245. Wolf MT, van Vlem B, Hennies HC, et al. Telomeric refinement of the MCKD1 locus on chromosome 1q21. Kidney Int 2004;66:580–5.
246. Mollet G, Salomon R, Gribouval O, et al. The gene mutated in juvenile nephronophthisis type 4 encodes a novel protein that interacts with nephrocystin. Nat Genet 2002;32:300–5.
247. Otto EA, Schermer B, Obara T, et al. Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination. Nat Genet 2003;34:413–20.
248. Olbrich H, Fliegauf M, Hoefele J, et al. Mutations in anovel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat Genet 2003;34:455–9.
249. Boichis H, Passwell J, David R, et al. Congenital hepatic fibrosis and nephronophthisis. A family study. Q J Med 1973;42:221–33.
250. Fernandez-Rodriguez R, Morales JM, Martinez R, et al. Senior- Loken syndrome (nephronophthisis and pigmentary retinopathy) associated to liver fibrosis: a family study. Nephron 1990;55: 74–7.
251. Proesmans W, Van Damme B, Macken J. Nephronophthisis and tapetoretinal degeneration associated with liver fibrosis. Clin Nephrol 1975;3:160–4.
252. Hunter AG, Rothman SJ, Hwang WS, et al. Hepatic fibrosis, polycystic kidney, colobomata and encephalopathy in siblings. Clin Genet 1974;6:82–9.
253. Gentile M, Di Carlo A, Susca F, et al. COACHsyndrome: report of two brothers with congenital hepatic fibrosis, cerebellar vermis hypoplasia, oligophrenia, ataxia, and mental retardation. Am J Med Genet 1996;64:514–20.
254. Lewis SM, Roberts EA, Marcon MA, et al. Joubert syndrome with congenital hepatic fibrosis: an entity in the spectrum of oculo-encephalo-hepato-renal disorders. Am J Med Genet 1994;52:419–26.
255. Foell D, August C, Frosch M, et al. Early detection of severe cholestatic hepatopathy in COACHsyndrome. Am J Med Genet 2002;111:429–34.
256. Kirchner GI, Wagner S, Flemming P, et al. COACH syndrome associated with multifocal liver tumors. Am J Gastroenterol 2002;97:2664–9.
257. Coppola G, Vajro P, De Virgiliis S, et al. Cerebellar vermis defect, oligophrenia, congenital ataxia, and hepatic fibrocirrhosiswithout coloboma and renal abnormalities: report of three cases. Neuropediatrics 2002;33:180–5.
258. Louie CM, Gleeson JG. Genetic basis of Joubert syndrome and related disorders of cerebellar development. Hum Mol Genet 2005;14(spec no. 2):R235–42.
259. Parisi MA, Bennett CL, Eckert ML, et al. The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome. Am J Hum Genet 2004;75:82–91.
260. Caroli J. Diseases of the intrahepatic biliary tree. Clin Gastroenterol 1973;2:147–61.
261. Mall JC, Chahremani GG, Boyer JL. Caroli’s disease associated with congenital hepatic fibrosis and renal tubular ectasia. Gastroenterology 1974;66:1029–53.
262. Erlinger S. [Cystic dilatation of the biliary tract]. Rev Prat 2000; 50:2136–41.
263. Hoglund M, Muren C, Schmidt D. Caroli’s disease in two sisters. Diagnosis by ultrasonography and computed tomography. Acta Radiol 1989;30:459–62.
264. Tsuchida Y, Sato T, Sanjo K, et al. Evaluationof long-termresults of Caroli’s disease: 21 years’ observation of a familywith autosomal “dominant” inheritance, and review of the literature. Hepatogastroenterology 1995;42:175–81.
265. Sgro M, Rossetti S, Barozzino T, et al. Caroli’s disease: prenatal diagnosis, postnatal outcome and genetic analysis. Ultrasound Obstet Gynecol 2004;23:73–6.
266. Jordan D, Harpaz N, Thung SN. Caroli’s disease and adult polycystic kidney disease: a rarely recognized association. Liver 1989;9:30–5.
267. Guntz PH, Coppo B, Lorimier G, et al. La maladie de Caroli unilobaire. J Chir (Paris) 1991;128:167–81.
268. Senyuz OF, Yesildag E, Kuruoglu S, et al. Caroli’s disease in children: is it commonly misdiagnosed? Acta Paediatr 2005;94:117–20.
269. Fevery J, Tanghe W, Kerremans R, et al. Congenital dilatation of the intrahepatic bile ducts associated with the development of amyloidosis. Gut 1972;13:604–9.
270. Fozard JB, Wyatt JI, Hall RI. Epithelial dysplasia in Caroli’s disease. Gut 1989;30:1150–3.
271. Etienne JC, Bouillot JL, Alexandre JH. Cholangiocarcinome développé sur maladie de Caroli. J Chir (Paris) 1987;124:161–4.
272. Choi BI, Yeon KM, Kim SH, et al. Caroli disease: central dot sign in CT. Radiology 1990;174:161–3.
273. Takehara Y, Takahashi M, Naito M, et al. Caroli’s disease associated with polycystic kidney: its noninvasive diagnosis. Radiat Med 1989;7:13–15.
274. Hopper KD. The role of computedtomography inthe evaluation of Caroli’s disease. Clin Imaging 1989;13:68–73.
275. Hussman KL, Friedwald JP, Gollub MJ, et al. Caroli’s disease associatedwith infantile polycystic kidney disease. JUltrasound Med 1991;10:235–7.
276. Sood GK, Mahapatra JR, Khurana A, et al. Caroli disease: computedtomographic diagnosis. Gastrointest Radiol 1991;16:243–4.
277. Krause D, Cercueil JP, Dranssart M, et al. MRI for evaluating congenital bile duct abnormalities. J Comput Assist Tomogr 2002;26:541–52.
278. Fain JS, Lewin KJ. Intrahepatic biliary cysts in congenital biliary atresia. Arch Pathol Lab Med 1989;113:1383–6.
279. Takahashi A, Tsuchida Y, Hatakeyama S, et al. A peculiar form of multiple cystic dilatation of the intrahepatic biliary system found in a patient with biliary atresia. J Pediatr Surg 1997;32: 1776–9.
280. Landing BH. Considerations on the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst. The concept of infantile obstructive cholangiopathy. Prog Pediatr Surg 1974;6:113–39.
281. Ryckman F, Fisher R, Pedersen S, et al. Improved survival in biliary atresia patients in the present era of liver transplantation. J Pediatr Surg 1993;28:382–5; discussion 386.
282. Todani T, Watanabe Y, Narusue M, et al. Congential bile duct cysts. Classification, operative procedures and review of thirtyseven cases including cancer arising from choledochal cyst. Am J Surg 1977;134:263–9.
283. Burns C, Kuhns JG, Wieman TJ. Cholangiocarcinoma in association withmultiple biliary microhamartomas. Arch Pathol Lab Med 1990;114:1287–9.
284. Jain D, Sarode VR, Abdul-Karim FW, et al. Evidence for the neoplastic transformation of Von-Meyenburg complexes. Am J Surg Pathol 2000;24:1131–9.
285. Eguchi S, Tajima Y, Yanaga K, et al. Hilar bile duct cancer associated with preoperatively undetectable von Meyenburg complex –report of a case. Hepatogastroenterology 2004;51:1301–3.
286. Melnick PJ. Polycystic liver. Analysis of seventy cases. Arch Pathol 1955;59:162–72.
287. Karhunen PJ. Adult polycystic liver disease and biliary microhamartomas (Von Meyenburg’s complexes). Acta Pathol Microbiol Immunol Scand [A] 1986;94:397–400.
288. Tsui WM. How many types of biliary hamartomas and adenomas are there? Adv Anat Pathol 1998;5:16–20.
289. Redston MS, Wanless IR. The hepatic von Meyenburg complex: prevalence and association with hepatic and renal cysts among 2843 autopsies [corrected]. Mod Pathol 1996;9:233–7.
290. Ohta W, Ushio H. Histological reconstruction of von Meyenburg’s complex on the liver surface. Endoscopy 1984;16:71–4.
291. Grimm PC, Crocker JF, Malatjalian DA, et al. The microanatomy of the intrahepatic bile duct in polycystic disease: comparison of the cpk mouse and human. J Exp Pathol 1990;71: 119–31.
292. Ramos A, Torres VE, Holley KE, et al. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med 1990; 114:180–4.
293. Lev-Toaff AS, Bach AM, Wechsler RJ, et al. The radiologic and pathologic spectrum of biliary hamartomas. AJR Am J Roentgenol 1995;165:309–13.
294. Mortele B, Mortele K, Seynaeve P, et al. Hepatic bile duct hamartomas (von Meyenburg complexes): MR and MR cholangiography findings. J Comput Assist Tomogr 2002;26:438–43.
295. Bruegel M, Rummeny EJ, Gaa J. Image of the month. Multiple biliary hamartomas as an incidental finding in a patient with neuroendocrine carcinoma of the pancreas. Gastroenterology 2005;128:259; answer 523.
296. Milutinovic J, Schabel SI, Ainsworth SK. Autosomal dominant polycystic kidney disease with liver and pancreatic involvement in early childhood. Am J Kidney Dis 1989;13:340–4.
297. Gabow PA. Autosomal dominant polycystic kidney disease. In: Gardner KD Jr, Bernstein J, eds. The cystic kidney. Dordrecht: Kluwer Academic Publishers, 1990:295–326.
298. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993;329:332–42.
299. Gabow PA, Johnson AM, Kaehny WD, et al. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990;11:1033–7.
300. Mousson C, Rabec M, Cercueil JP, et al. Caroli’s disease and autosomal dominant polycystic kidney disease: a rare association? Nephrol Dial Transplant 1997;12:1481–3.
301. Klinkert J, Koopman MG, Wolf H. Pregnancy in a patient with autosomal-dominant polycystic kidney disease and congenital hepatic fibrosis. Eur J Obstet Gynecol Reprod Biol 1998;76: 45–7.
302. Grunfeld JP, Albouze G, Junger P. Liver changes and complications in adult polycystic kidney disease. Adv Nephrol 1985;14:1.
303. Leier CV, Baker PB, Kilman JW, et al. Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Intern Med 1984;100:683–8.
304. Sutters M, Germino GG. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med 2003;141:91–101.
305. Ariza M, Alvarez V, Marin R, et al. A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes. J Med Genet 1997;34:587–9.
306. Consortium EPKD. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 1994;77:881–94.
307. Reeders ST. Thegenetics of renal cystic disease. In: Garder KDJr, Bernstein J, eds. The cystic kidney. Dordrecht: Kluwer Academic Publishers, 1990;117–46.
308. Hughes J, Ward CJ, Peral B, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995;10:151–60.
309. Geng L, Segal Y, Peissel B, et al. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996;98:2674–82.
310. Ibraghimov-Beskrovnaya O, Dackowski WR, Foggensteiner L, et al. Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A 1997;94:6397–402.
311. Ward CJ, Turley H, Ong AC, et al. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci USA 1996; 93:1524–8.
312. Kottgen M, Walz G. Subcellular localization and trafficking of polycystins. Pflugers Arch 2005;451:286–93.
313. Kimberling WJ, Kumar S, Gabow PA, et al. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 1993;18:467–72.
314. Veldhuisen B, Saris JJ, de Haij S, et al. A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). Am J Hum Genet 1997;61:547–55.
315. Schneider MC, Rodriguez AM, Nomura H, et al. A gene similar to PKD1mapstochromosome4q22: a candidate gene for PKD2. Genomics 1996;38:1–4.
316. Peters DJ, Spruit L, Saris JJ, et al. Chromosome4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet 1993;5:359–62.
317. Wu G, D’Agati V, Cai Y, et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 1998;93:177–88.
318. Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996;272:1339–42.
319. Al-Bhalal L, Akhtar M. Molecular basis of autosomal dominant polycystic kidney disease. Adv Anat Pathol 2005;12:126–33.
320. Yoder BK, Hou X, Guay-Woodford LM. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 2002;13:2508–16.
321. Nauli SM, Zhou J. Polycystins and mechanosensation in renal and nodal cilia. Bioessays 2004;26:844–56.
322. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003;4:517–29.
323. Pei Y. Nature and nurture on phenotypic variability of autosomal dominant polycystic kidney disease. Kidney Int 2005; 67:1630–1.
324. Fain PR, Mc Fann KK, Taylor MR, et al. Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int 2005;67:1256–67.
325. Perrone RD, Grubman SA, Rogers LC, et al. Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium. Am J Physiol 1995;269(3 pt 1): G335–45.
326. Witzleben C, Steigman C. Immunohistochemically defined duct element patterns in pediatric liver diseases. Lab Invest 1990;69:8P.
327. Piccoli DA, Witzleben CL. Disorders of the intrahepatic bile ducts. In: Walker WA, Durie RP, Hamilton JR, et al., eds. Pediatric gastrointestinal disease: pathophysiology, diagnosis, management Philadelphia: BC Decker, 1991:1124–40.
328. Patterson M, Gonzalez-Vitale JC, Fagan CJ. Polycystic liver disease. A study of cyst fluid constituents. Hepatology 1982;2: 475–8.
329. Everson GT, Emmett M, Brown WR, et al. Functional similarities of hepatic cystic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin. Hepatology 1990;11:557–65.
330. Itai Y, Ebihara R, Eguchi N, et al. Hepatobiliary cysts in patients with autosomal dominant polycystic kidney disease: prevalence and CT findings. AJR Am J Roentgenol 1995;164:339–42.
331. Kida T, Nakanuma Y, Terada T. Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers with solitary nonparasitic cysts: an autopsy study. Hepatology 1992; 16:334–40.
332. Desmet V. Pathogenesis of ductal plate abnormalities. Mayo Clinic Proc 1998;73:80–9.
333. Torra R, Badenas C, Darnell Aet al. [Clinical, genetic and molecular studies on autosomal dominant polycystic kidney disease]. Med Clin (Barc) 1998;110:481–7.
334. Pirson Y, Lannoy N, Peters D, et al. Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2. Hepatology 1996;23:249–52.
335. Iglesias DM, Palmitano JA, Arrizurieta E, et al. Isolated polycystic liver disease not linked to polycystic kidney disease 1 and 2. Dig Dis Sci 1999;44:385–8.
336. Li A, Davila S, Furu L, et al. Mutations in PRKCSHcause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 2003;72:691–703.
337. Drenth JP, Tahvanainen E, te Morsche RH, et al. Abnormal hepatocystin caused by truncating PRKCSH mutations leads to autosomal dominant polycystic liver disease. Hepatology 2004;39:924–31.
338. Tahvanainen P, Tahvanainen E, Reijonen H, et al. Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families. J Hepatol 2003;38:39–43.
339. Davila S, Furu L, Gharavi AG, et al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 2004;36:575–7.
340. Qian Q, Li A, King BF, et al. Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003;37:164–71.
341. Zimmerman K. Bwitrage zur kenntnis einiger Drusen und epithelien. Arch Mikrosk Anat Entwicklungmech 1898;52:552–706.
342. Wheatley DN. Primary cilia in normal and pathological tissues. Pathobiology 1995;63:222–38.
343. Rosenbaum JL, Witman GB. Intraflagellar transport. Nat Rev Mol Cell Biol 2002;3:813–25.
344. Delmas P, Padilla F, Osorio N, et al. Polycystins, calcium signaling, and human diseases. Biochem Biophys Res Commun 2004; 322:1374–83.
345. Montell C. The latest waves in calcium signaling. Cell 2005; 122:157–63.
346. Mc Grath J, Somlo S, Makova S, et al. Two populations of node monocilia initiate left-right asymmetry in the mouse. Cell 2003;114:61–73.
347. Levin M. Motor protein control of ion flux is an early step in embryonic left-right asymmetry. Bioessays 2003;25:1002–10.
348. Tekotte H, Davis I. Intracellular m RNA localization: motors move messages. Trends Genet 2002;18:636–42.
349. Ong AC, Harris PC. Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int 2005;67:1234–47.
350. Ward CJ, Yuan D, Masyuk TV, et al. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum Mol Genet 2003;12:2703–10.
351. Watanabe J, Asaka Y, Tanaka T, et al. Measurement of NADPHcytochrome P-450 reductase content in rat liver sections by quantitative immunohistochemistry with a video image processor. J Histochem Cytochem 1994;42:1161–7.
352. Ansley SJ, Badano JL, Blacque OE, et al. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 2003;425:628–33.
353. Pazour GJ, Dickert BL, Vucica Y, et al. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J Cell Biol 2000; 151:709–18.
354. Hou X, Mrug M, Yoder BK, et al. Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. J Clin Invest 2002;109:533–40.
355. Mai W, Chen D, Ding T, et al. Inhibition of Pkhd1 impairs tubulomorphogenesis of cultured IMCD cells. Mol Biol Cell 2005;16:4398–409.
356. Watnick T, Germino G. From cilia to cyst. Nat Genet 2003; 34:355–6.
357. Ong AC, Wheatley DN. Polycystic kidney disease –the ciliary connection. Lancet 2003;361:774–6.
358. Ong AC, Ward CJ, Butler RJ, et al. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol 1999;154:1721–9.
359. Watnick TJ, Torres VE, Gandolph MA, et al. Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease. Mol Cell 1998;2:247–51.
360. Nichols MT, Gidey E, Matzakos T, et al. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology 2004;40:836–46.
361. Nagasawa Y, Matthiesen S, Onuchic LF, et al. Identification and characterization of Pkhd1, the mouse orthologue of the human ARPKD gene. J Am Soc Nephrol 2002;13:2246–58.
362. Edmondson H. Differential diagnosis of tumors and tumorlike lesions of liver in infancy and childhood. AMA J Dis Child 1956;91:168–86.
363. De Maioribus CA, Lally KP, Sim K, et al. Mesenchymal hamartomaof the liver. A35-year review. Arch Surg 1990;125:598–600.
364. Stringer MD, Alizai NK. Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg 2005;40:1681–90.
365. Gornicka B, Ziarkiewicz-Wroblewska B, Wroblewski T, et al. Myoid hamartoma of the liver –a novel variant of hamartoma developing in the hilar region and imitating a malignant liver tumor. Med Sci Monit 2004;10:CS23–6.
366. Dehner LP, Ewing SL, Summer HW. Infantile mesenchymal hamartoma of the liver. Histologic and ultrastructural observations. Arch Pathol 1975;99:379–81.
367. Lennington WJ, Gray GFJr, Page DL. Mesenchymal hamartoma of liver. A regional ischemic lesion of a sequestered lobe. Am J Dis Child 1993;147:193–6.
368. O’Sullivan MJ, Swanson PE, Knoll J, et al. Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr Dev Pathol 2001;4:482–9.
369. Lauwers GY, Grant LD, Donnelly WH, et al. Hepatic undifferentiated (embryonal) sarcomaarising in a mesenchymal hamartoma. Am J Surg Pathol 1997;21:1248–54.
370. Stocker JT, Ishak KG. Mesenchymal hamartoma of the liver: report of 30 cases and review of the literature. Pediatr Pathol 1983;1:245–67.
371. Cook JR, Pfeifer JD, Dehner LP. Mesenchymal hamartoma of the liver in the adult: association with distinct clinical features and histological changes. Hum Pathol 2002;33:893–8.
372. Ishak KG, Sharp HL. Developmental abnormality and liver disease in childhood. In: Mac Sween RNM, et al. Pathology of the liver. 3rd ed. Edinburgh: Churchill Livingstone, 1994:83–122.
373. Otani Y, Takayasu H, Ishimaru Y, et al. Secretion and expression of epithelial markers supports the biliary origin of solitary nonparasitic cyst of the liver in infancy. J Pediatr Surg 2005;40:e27–30.
374. Lin CC, Lin SC, Ko WC, et al. Adenocarcinoma and infection in a solitary hepatic cyst: a case report. World J Gastroenterol 2005;11:1881–3.
375. Raboei E, Luoma R. Definitive treatment of congenital liver cyst with alcohol. J Pediatr Surg 2000;35:1138–9.
376. Reichel S, Alzen G, Keller KM, et al. [Congenital, solitary hepatic cyst: observation of the development from birth upon the intervention in the 5th year of life]. Klin Padiatr 2002;214: 332–3.
377. Friedrich N. Cyste mit flimmerepithel in der leber. Arch Pathol Anat 1857;11:466–9.
378. Kim S, White FV, Mc Alister W, et al. Ciliated hepatic foregut cyst in a young child. J Pediatr Surg 2005;40:e51–3.
379. Vick DJ, Goodman ZD, Deavers MT, et al. Ciliated hepatic foregut cyst: a study of six cases and review of the literature. Am J Surg Pathol 1999;23:671–7.
380. Koletsa T, Tzioufa V, Michalopoulos A, et al. Ciliated hepatic foregut cyst communicating with the gallbladder. Virchows Arch 2005;446:200–1.
381. Rodriguez E, Soler R, Fernandez P. MRimagings of ciliated hepatic foregut cyst: an unusual cause of fluid-fluid level within a focal hepatic lesion (2005. 4b). Eur Radiol 2005;15:1499–501.
382. Furlanetto A, Dei Tos AP. Squamous cell carcinoma arising in a ciliated hepatic foregut cyst. Virchows Arch 2002;441:296–8.
383. Puente SG, Bannura GC. Radiological anatomy of the biliary tract. Variations and congenital abnormalities. World J Surg 1983;7:271–6.
384. Hashmonai M, Kam I, Schramek A. The etiology of “white bile” in the biliary tree. J Surg Res 1984;37:479–86.
385. Markle GB. Agenesis of the common bile duct. Arch Surg 1981;116:350–2.
386. Schwartz MZ, Hall RJ, Reubner B, et al. Agenesis of the extrahepatic bile ducts: report of five cases. J Pediatr Surg 1990;25:805–7.
387. Sherlock S. Diseases of the liver and biliary system. Oxford: Blackwell Scientific Publications, 1989.
388. Luschka H. Die Anatomie des Menschlichen Bauches Bd II. Tubingen: Laup und Siebeckle, 1863:248–55.
389. Sharif K, de Ville de Goyet J. Bile duct of Luschka leading to bile leak after cholecystectomy –revisiting the biliary anatomy. J Pediatr Surg 2003;38:E21–3.
390. Kitami M, Murakami G, Suzuki D, et al. Heterogeneity of subvesical ducts or the ducts of Luschka: a study using dripinfusion cholangiography-computed tomography in patients and cadaver specimens. World J Surg 2005;29:217–23.
391. Boyden E. The problem of the double ductus choledochus (an interpretation of an accessory bile duct found attached to the pars superior of the duodenum). Anat Rec 1932;55:71–93.
392. Lamah M, Karanjia ND, Dickson GH. Anatomical variations of the extrahepatic biliary tree: review of the world literature. Clin Anat 2001;14:167–72.
393. Kodama T, Iseki J, Murata N, et al. Duplication of common bile duct –a case report. Jpn J Surg 1980;10:67–71.
394. Yamashita K, Oka Y, Urakami A, et al. Double common bile duct: a case report and a review of the Japanese literature. Surgery 2002;131:676–81.
395. Yamataka A, Yanai T, Hosoda Y, et al. A case of biliary atresia with duplication of the common bile duct. J Pediatr Surg 2001;36:506–7.
396. Casebolt BT. Duplication of the commonbile duct. Case report. Mo Med 1973;70:171–4 passim.
397. Neuhauser EB, Elkin M, Landing B. Congenital direct communication between biliary systemand respiratory tract. AMA Am J Dis Child 1952;83:654–9.
398. Hourigan JS, Carr MG, Burton EM, et al. Congenital bronchobiliary fistula:MRIappearance. Pediatr Radiol 2004;34:348–50.
399. Chan YT, Ng WD, Mak WP, et al. Congenital bronchobiliary fistula associated with biliary atresia. Br J Surg 1984;71:240–1.
400. Di Fiore JW, Alexander F. Congenital bronchobiliary fistula in association with right-sided congenital diaphragmatic hernia. J Pediatr Surg 2002;37:1208–9.
401. Weitzman JJ, Cohen SR, Woods LO Jr, et al. Congenital bronchobiliary fistula. J Pediatr 1968;73:329–34.
402. Sane SM, Sieber WK, Girdany BR. Congenital bronchobiliary fistula. Surgery 1971;69:599–608.
403. Dijkstra C. Galuitstorting in de buikholte bij een zuigeling. Maandsch Kindergeneesk 1932;1:409–14.
404. Xanthakos SA, Yazigi NA, Ryckman FC, et al. Spontaneous perforation of the bile duct in infancy: a rare but important cause of irritability and abdominal distension. J Pediatr Gastroenterol Nutr 2003;36:287–91.
405. Alagille D. Cholestasis in the first three months of life. In:Popper H, Schaffner F, eds. Progress in liver disease. Vol. 1. New York: Grune and Stratton, 1979:471–85.
406. Gorelick FS, Dobbins JW, Burrell M, et al. Biliary tract abnormalities in patients with arteriohepatic dysplasia. Dig Dis Sci 1982;27:815–20.
407. Morelli A, Pelli MA, Vedovelli A, et al. Endoscopic retrograde cholangiopancreatography study in Alagille’s syndrome: first report. Am J Gastroenterol 1983;78:241–4.
408. Krant SM, Swenson O. Biliary duct hypoplasia. J Pediatr Surg 1973;8:301–7.
409. Afroudakis A, Kaplovitz N. Liver histopathology in chronic common bile duct stenosis due to chronic alcoholic pancreatitis. Hepatology 1981;1:65–72.
410. Sherlock S. The liver in infancy and childhood. In: Sherlock S, ed. Diseases of the liver and biliary system. 8th ed. Oxford: Blackwell Scientific Publications, 1989:501–22.
411. Ryckman FC, Noseworthy J. Neonatal cholestatic conditions requiring surgical reconstruction. Semin Liver Dis 1987;7:134–54.
412. Okada T, Sasaki F, Ueki S, et al. Postnatal management for prenatally diagnosed choledochal cysts. J Pediatr Surg 2004;39: 1055–8.
413. Wong AM, Cheung YC, Liu YH, et al. Prenatal diagnosis of choledochal cyst using magnetic resonance imaging: a case report. World J Gastroenterol 2005;11:5082–3.
414. Alonso Lej F, Rever WB, Pessagna DJ. Congenital choledochal cyst, with a report of two and an analysis of 94 cases. Surg Gynecol Obstet 1959;108:1–30.
415. Hadad AR, Westbrook KC, Campbell GS, et al. Congenital dilatation of the bile ducts. Am J Surg 1976;132:799–804.
416. Longmire WP, Mandiola SA, Gordon HE. Congenital cystic disease of the liver and biliary system. Ann Surg 1971;174:711–24.
417. Rizzo RJ, Szucs RA, Turner MA. Congenital abnormalities of the pancreas and biliary tree in adults. Radiographics 1995;15:49–68; quiz 147–8.
418. Tandon RK, Grewal H, Anand AC, et al. Caroli’s syndrome: a heterogeneous entity. Am J Gastroenterol 1990;85:170–3.
419. Yamaguchi M. Congenital choledochal cyst. Analysis of 1. 433 patients in the Japanese literature. Am J Surg 1980;140:653–7.
420. Chongsrisawat V, Roekwibunsi S, Mahayosnond A, et al. Spontaneous choledochal cyst rupture in a child. Pediatr Surg Int 2004;20:811–12.
421. Soreide K, Korner H, Havnen J, et al. Bile duct cysts in adults. Br J Surg 2004;91:1538–48.
422. Lam AH, Lam VK. Choledochal cyst with biliary atresia in an infant. Australas Radiol 1987;31:384–5.
423. Joseph VT. Surgical techniques and long-term results in the treatment of choledochal cyst. J Pediatr Surg 1990;25:782–7.
424. Jordan PH Jr, Goss JA Jr, Rosenberg WR, et al. Some considerations for management of choledochal cysts. Am J Surg 2004; 187:434–9.